Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2563729 | Pharmacology & Therapeutics | 2007 | 12 Pages |
Abstract
Nongenomic estrogen signaling pathways involve extranuclear estrogen receptors or function independently from estrogen receptors. These pathways participate in neuroprotection elicited by the hormone. Additional nongenomic neuroprotective effects are attributable to antioxidant and antiinflammatory actions of estrogens. Numerous chemical modifications to afford neuroprotective compounds from estrogens while eliminating estrogenicity and maintaining or enhancing nongenomic neuroprotection have been described. This review highlights recent structure–activity studies that revealed the importance of antioxidant effects for neuroprotective estrogen analogues and derivatives.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Laszlo Prokai, James W. Simpkins,